Literature DB >> 3485834

Messenger RNA for plasminogen activator inhibitor.

M Sawdey, T Ny, D J Loskutoff.   

Abstract

We report here the identification and preliminary characterization of the messenger RNA coding for a Mr 50,000 plasminogen activator inhibitor (PAI) synthesized by cultured bovine aortic endothelial cells. Polyadenylated RNA was prepared from these cells and translated in a rabbit reticulocyte lysate in vitro translation system. When the 35S methionine labeled translation products were immunoprecipitated with monospecific antiserum to PAI and analyzed by SDS-PAGE and autoradiography, a single major polypeptide of Mr 40,000 was revealed. Competition experiments were performed to determine the relationship of the immunoprecipitated polypeptide to the PAI. The amount of 35S-labeled immunoprecipitate was greatly decreased by the presence of the purified PAI, consistent with the conclusion that the Mr 40,000 band represented the translation product of PAI mRNA. This mRNA migrated with a sedimentation coefficient of 22s when analyzed by sucrose gradient centrifugation. The in vitro translation assay was used to determine the relative amount of PAI mRNA in cells cultured in calf serum purchased from different vendors. The level of PAI mRNA varied by at least eight-fold depending on the serum employed, suggesting that expression of the PAI gene is subject to regulation by external factors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485834     DOI: 10.1016/0049-3848(86)90225-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Variability in messenger RNA levels in human umbilical vein endothelial cells of different lineage and time in culture.

Authors:  D Dichek; T Quertermous
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

2.  Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

Authors:  T Ny; M Sawdey; D Lawrence; J L Millan; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter.

Authors:  A J van Zonneveld; S A Curriden; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.

Authors:  B A Konkle; D Ginsburg
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

5.  Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells.

Authors:  R R Schleef; D J Loskutoff; T J Podor
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

6.  Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.

Authors:  H Pannekoek; H Veerman; H Lambers; P Diergaarde; C L Verweij; A J van Zonneveld; J A van Mourik
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.